Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intractable chronic lymphocytic leukemia and interferon.

R Schrek1

  • 1Research Service, VA Hospital, Hines, IL.

Medical Hypotheses
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro effects of oxytetracycline on normal and malignant cells.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

In vitro studies on the physiology of cells; interactions of thymic cells and an oxidation-reduction indicator, 2,6-dichlorophenolindophenol.

Archives of pathology·2010
Same author

Studies in vitro on cellular physiology; the effect of x-rays on the survival of cells.

Radiology·2010
Same author

Etiologic factors in patients with carcinoma of the penis and in control groups.

The American journal of pathology·2010
Same author

Histologic changes in lymphocytes exposed to X-rays and other injurious agents.

The Proceedings of the Institute of Medicine of Chicago·2010
Same author

Studies in vitro on the physiology of cells; factors affecting the delayed cytocidal action of x-rays.

Journal of cellular and comparative physiology·2010

Interferon may treat chronic lymphocytic leukemia (CLL) due to similar radioresistance in lymphocytes and comparable patient response rates. This suggests interferon

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is a B-cell malignancy with variable treatment responses.
  • Intractable CLL presents a therapeutic challenge.
  • Hairy cell leukemia shares some in vitro characteristics with CLL.

Purpose of the Study:

  • To explore the potential therapeutic utility of interferon in intractable chronic lymphocytic leukemia (CLL).

Main Methods:

  • Comparative analysis of in vitro radioresistance between lymphocytes from intractable CLL patients and hairy cells.
  • Examination of the incidence of intractable CLL and correlation with interferon treatment response rates in CLL patients.

Main Results:

  • Observed similarity in in vitro radioresistance between intractable CLL lymphocytes and hairy cells.

Related Experiment Videos

  • Noted comparable incidence rates between intractable CLL patients and CLL patients who respond to interferon therapy.

    • Conclusions:

    • The findings support the hypothesis that interferon may be a viable treatment option for intractable chronic lymphocytic leukemia.
    • Further investigation into interferon's efficacy for CLL is warranted.